Related Experiment Videos
Bioavailability of valproic acid under fasting/nonfasting regimens
Journal of Clinical Pharmacology
|January 1, 1980
Summary
Valproic acid syrup offers faster absorption than capsules, reaching peak levels within an hour. Food intake timing impacts absorption speed but not overall drug extent, with a consistent 12-hour half-life.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Clinical Pharmacokinetics
Background:
- Valproic acid is a widely used antiepileptic and mood-stabilizing drug.
- Understanding its absorption characteristics is crucial for optimizing therapeutic efficacy.
- Different pharmaceutical formulations and administration conditions can influence drug bioavailability.
Purpose of the Study:
- To compare the absorption rate and extent of valproic acid from syrup versus capsule formulations.
- To investigate the effect of meal timing (fasting, before meal, after meal) on valproic acid absorption.
- To determine the pharmacokinetic profile, including serum half-life, of valproic acid.
Main Methods:
- A pharmacokinetic study comparing two valproic acid formulations (syrup and capsule).
- Administration of valproic acid under different meal conditions: fasting, immediately before a meal, and immediately after a meal.
- Serial blood sampling to measure serum valproic acid concentrations over time.
- Pharmacokinetic analysis to determine absorption parameters and serum half-life.
Main Results:
- Valproic acid absorption was significantly faster from the syrup formulation compared to the capsule formulation.
- Peak serum concentrations were achieved within one hour for the syrup formulation.
- Administration while fasting or immediately before a meal resulted in more rapid absorption than administration immediately after a meal.
- The overall extent of absorption was similar across all tested formulations and meal regimens.
- The estimated serum half-life of valproic acid was 12 hours.
Conclusions:
- Valproic acid syrup provides faster absorption and quicker achievement of peak serum levels compared to capsules.
- Meal timing influences the rate but not the extent of valproic acid absorption.
- These findings support the use of syrup formulations for faster therapeutic onset and provide guidance on optimal administration timing relative to meals.